Genetic Epidemiology of Responses to Antihypertensives

Plain-language summary

This study examined the genetic basis of how people respond to blood pressure (hypertension) medications. Two blood pressure drugs (Hydrochlorothiazide and Candesartan) were used, and people with primary (essential) hypertension could take part. It was carried out as a study with no assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Mayo Clinic

Intervention

Hydrochlorothiazide, Candesartan

Start date

2/1/1997

Estimated completion

1/1/2008

Countries

United States

Related genes

Locations

• Rochester, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Primary (essential) hypertension